New York, Feb 12, 2026, 08:33 EST — Premarket.
- Hinge Health edged up 0.4% premarket, following a 17.3% surge in the previous session.
- Digital MSK care provider is forecasting 2026 revenue between $732 million and $742 million, following a solid fourth quarter.
- RBC held onto its Outperform call, though it cut the price target, citing better margins and the stock’s valuation.
Hinge Health climbed 0.4% to $38.90 ahead of Thursday’s open, adding to Wednesday’s surge that saw the stock jump 17.3% and end the session at $38.76. The rally followed the company’s outlook for 2026. 1
This shift is significant—investors are once more rewarding recent health tech listings that deliver growth with discipline. Hinge Health is putting both on the table: accelerating revenue, improving margins, and a buyback aimed at shrinking the share count.
Hinge Health made its public debut in May, pricing shares at $32—a notable gauge for IPO appetite after a lengthy drought in new listings. 2
Hinge Health’s fourth-quarter numbers showed a 46% jump in revenue, reaching $170.7 million. Adjusted diluted EPS came in at $0.49. CEO Daniel Perez called it “an exceptional quarter,” citing higher win rates and an uptick in eligible lives to close out the year. 3
The company is projecting revenue of $732 million to $742 million for 2026. For the first quarter, it sees revenue coming in between $171 million and $173 million, and puts its adjusted operating margin—excluding stock-based compensation and some other items—at roughly 18% at the midpoint.
The company filed its quarterly results and accompanying documents via an 8-K, according to an SEC filing. 4
RBC Capital Markets slashed its price target to $50 from the previous $60, but kept its Outperform rating in place. The firm pointed to “another solid quarter of revenue outperformance and margin expansion.” RBC noted the company still has “a long runway ahead” as it moves into a bigger addressable market. The stock, they added, is trading at roughly three times their projected 2027 revenue. 5
Hinge Health offers digital solutions for musculoskeletal issues—think joint or muscle pain—to employers and health insurers. The company claims its software and remote clinical staff can provide more care, driving down total medical costs.
Still, investors got a reality check this quarter: Hinge Health logged a hefty GAAP operating loss for 2025, despite calling attention to adjusted profits. The distance between their GAAP and non-GAAP numbers — and how fast it closes — looms large for a stock that’s already been volatile since its IPO. 6
Investors are now waiting for the annual Form 10-K, with management indicating the filing will come “in the coming weeks.” The next earnings update lands May 7. 7
